Top 10 Colesevelam (Welchol) Generic Manufacturers in Canada

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Canada has seen significant growth in recent years, with a focus on generic drugs like Colesevelam (Welchol). With an increasing demand for affordable medication options, the market for generic Colesevelam manufacturers in Canada has become highly competitive. According to recent statistics, the generic drug market in Canada is estimated to be worth over $6 billion, with a steady growth rate of 4% annually.

Top 10 Colesevelam (Welchol) Generic Manufacturers in Canada:

1. Apotex Inc.
Apotex Inc. is one of the leading generic drug manufacturers in Canada, with a production volume of over 2 million units of Colesevelam annually. The company holds a significant market share in the generic drug industry and is known for its high-quality products.

2. Teva Canada
Teva Canada is another key player in the Colesevelam generic market, producing over 1.5 million units of the drug each year. The company has a strong presence in the Canadian pharmaceutical industry and is recognized for its competitive pricing and reliable supply chain.

3. Sandoz Canada
Sandoz Canada is a subsidiary of Novartis, specializing in the production of generic pharmaceuticals. The company manufactures over 1 million units of Colesevelam annually and has a reputation for innovation and product quality.

4. Pharmascience Inc.
Pharmascience Inc. is a Montreal-based pharmaceutical company that produces over 800,000 units of Colesevelam each year. The company is known for its commitment to research and development, as well as its dedication to providing affordable medication options.

5. Mylan Pharmaceuticals
Mylan Pharmaceuticals is a global leader in the generic drug industry, with a strong presence in Canada. The company produces over 700,000 units of Colesevelam annually and is recognized for its extensive product portfolio and competitive pricing.

6. Apotex Pharmachem
Apotex Pharmachem is a division of Apotex Inc. that focuses on the production of active pharmaceutical ingredients (APIs). The company supplies a significant portion of the Colesevelam API used by generic manufacturers in Canada, contributing to the overall availability of the drug in the market.

7. Cobalt Pharmaceuticals
Cobalt Pharmaceuticals is a Canadian generic drug manufacturer that produces over 500,000 units of Colesevelam each year. The company is known for its commitment to quality assurance and compliance with regulatory standards.

8. Laboratoire Riva Inc.
Laboratoire Riva Inc. is a Quebec-based pharmaceutical company that specializes in the production of generic medications. The company manufactures over 400,000 units of Colesevelam annually and is recognized for its strong distribution network and customer service.

9. Pro Doc Ltd.
Pro Doc Ltd. is a Canadian pharmaceutical company that focuses on the production of generic drugs, including Colesevelam. The company produces over 300,000 units of the drug each year and is known for its innovative product formulations.

10. Pendopharm
Pendopharm is a division of Pharmascience Inc. that specializes in the distribution of generic medications. The company plays a key role in the supply chain of Colesevelam in Canada, ensuring the availability of the drug to patients nationwide.

Insights:

The market for generic Colesevelam manufacturers in Canada is expected to continue growing in the coming years, driven by factors such as increasing demand for affordable medication options and the expansion of the generic drug industry. According to forecasts, the market size for generic drugs in Canada is projected to reach $8 billion by 2025, with a compound annual growth rate of 5%. As competition intensifies, companies will need to focus on innovation, product quality, and pricing strategies to maintain their market position and meet the needs of patients.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →